Cluster randomised controlled trial of the effectiveness and cost-effectiveness of the Enhanced Management of home-Based Elders with Depression (EMBED) program in reducing depression among older adults receiving in-home aged care.

Silverchain0 个研究点目标入组 1,050 人开始时间: 2023年12月20日最近更新: 2024年1月15日

适应症

试验速览

暂无简介。

•.65 years of age or older.
•Silverchain CHSP (Commonwealth home support programme) or HCP (Home care package) client.
•Receipt of personal care, social, allied health or nursing services from Silverchain.
•Current depressive symptoms: Participants with depressive symptoms are identified in two steps: (i) screening using the first two items of the PHQ-9 (also known as the PHQ-2 screening tool) - a score of 2 or more is required: and (ii) administration of the full PHQ-9 - a score of 5 or more is required.

•Receiving only domestic support or gardening services as part of their CHSP or HCP service
•Current receipt of psychological therapy for low mood or depression outside of the trial (i.e., current treatment by a psychological practitioner such as psychologist, counsellor, or other health care professional)
•Moderate or severe cognitive impairment (A score of 18 or lower on the Telephone Administered Mini Mental State Examination (TMMSE), and/or presence of a diagnosis of cognitive impairment or dementia on the care record).
•Severe acute medical illness likely to complicate participation in the trial.
•Insufficient proficiency in English to take part in the trial.
•Difficulty communicating over the telephone and/or video call
•Diagnosis of one or more of the following psychiatric conditions: Schizophrenia or other psychotic disorder, bipolar disorder, alcohol or substance use disorder
•Presence of severe suicidal ideation (classified as high risk on the Columbia-Suicide Severity Rating Scale, with (i) an intention to act on suicidal thoughts or (ii) suicide attempts within previous 3 months)

发起方

Silverchain